Filing step-change
BIOGEN · 2026-09
Quarterly observations that moved versus the prior period in 2026-09. Facts only — not a call to act.
Narrative date 2026-09-30 · Evidence medium
BIOGEN's 100% gross margin accelerated to, up from 49.93%.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | 49.93 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 49.93 % | -18.09 | ▲ |
Cite this
Source: Samhati filing step-change for BIOGEN (2026-09). Observation: BIOGEN's 100% gross margin accelerated to, up from 49.93%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/biogen/q/2026-09
Other periods